Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

[HTML][HTML] Boron chemicals in drug discovery and development: Synthesis and medicinal perspective

BC Das, NK Nandwana, S Das, V Nandwana… - Molecules, 2022 - mdpi.com
A standard goal of medicinal chemists has been to discover efficient and potent drug
candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive …

Arginine metabolism: nitric oxide and beyond

G Wu, SM Morris Jr - Biochemical Journal, 1998 - portlandpress.com
Arginine is one of the most versatile amino acids in animal cells, serving as a precursor for
the synthesis not only of proteins but also of nitric oxide, urea, polyamines, proline …

Boron containing compounds as protease inhibitors

R Smoum, A Rubinstein, VM Dembitsky… - Chemical …, 2012 - ACS Publications
Proteases form one of the largest and more important groups of enzymes. They selectively
catalyze the hydrolysis of peptide bonds and can be divided into four major classes …

Boronic acid compounds as potential pharmaceutical agents

W Yang, X Gao, B Wang - Medicinal Research Reviews, 2003 - Wiley Online Library
Boronic acid compounds have been used, because of their unique structural features, for the
development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy …

Arginase as a potential biomarker of disease progression: a molecular imaging perspective

G S. Clemente, A van Waarde, I F. Antunes… - International Journal of …, 2020 - mdpi.com
Arginase is a widely known enzyme of the urea cycle that catalyzes the hydrolysis of L-
arginine to L-ornithine and urea. The action of arginase goes beyond the boundaries of …

Boron-containing inhibitors of synthetases

SJ Baker, JW Tomsho, SJ Benkovic - Chemical Society Reviews, 2011 - pubs.rsc.org
The use of boron in small-molecule pharmaceuticals is increasing. Boron's ubiquitous
occurrence in nature and the recent success of a boronic acid drug (Velcade®) in the clinic …

Catalysis by metal-activated hydroxide in zinc and manganese metalloenzymes

DW Christianson, JD Cox - Annual review of biochemistry, 1999 - annualreviews.org
▪ Abstract The metal-activated hydroxide ion is a critical nucleophile in metalloenzymes that
catalyze hydrolysis or hydration reactions. The most common metal used is zinc; …

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats

JH Kim, LJ Bugaj, YJ Oh… - Journal of applied …, 2009 - journals.physiology.org
There is increasing evidence that upregulation of arginase contributes to impaired
endothelial function in aging. In this study, we demonstrate that arginase upregulation leads …

Boron reagents in process chemistry: Excellent tools for selective reductions

ER Burkhardt, K Matos - Chemical reviews, 2006 - ACS Publications
Boranes and borohydride reagents have found utility in synthesis routes to a number of
pharmaceutical and other products. Boron reagents have become increasingly important for …